Details of the Drug Reposition

General Information of This Drug (ID: DMZJP2T)

• Drug Name: INCB50465 (DMZJP2T)

Information on Drug Reposition of This Drug

3 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Follicular lymphoma	DISVEUR6	2A80	Phase 2	[1]
Diffuse large B-cell lymphoma	DISSACK3	2A81	Phase 2	[1]
Marginal zone lymphoma	DISLZ4AO	2A85.0	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)